Attached files

file filename
EX-99.01 - EXHIBIT 99.01 - Inspyr Therapeutics, Inc.v391589_ex99-01.htm


 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): October 17, 2014 (October 16, 2014)


 

GENSPERA, INC.

(Exact name of registrant as specified in Charter)

  

Delaware   0001421204   20-0438951
(State or other jurisdiction of incorporation or organization)   (Commission File No.)   (IRS Employee Identification No.)

 

2511 N Loop 1604 W, Suite 204

San Antonio, TX 78258

(Address of Principal Executive Offices)

 

210-479-8112

(Issuer Telephone number)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

  

 
 

 

Item 8.01 Other Events.

  

On October 16, 2014, GenSpera, Inc. announced that Melanie Thomas, MD, MS is joining the company as a medical advisor. A copy of the press release is attached to this report as Exhibit 99.01.

 

Item 9.01. Financial Statements and Exhibits.

 

Exhibit      
No.   Description  
99.01   Press Release dated October 16, 2014  

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: October 17, 2014

  

  GenSpera, Inc.
   
  By:   /s/ Craig Dionne
      Craig Dionne
      Chief Executive Officer

 

 
 

 

INDEX OF EXHIBITS

 

Exhibit      
No.   Description  
99.01   Press Release dated October 16, 2014